Quality Review Excellence in Medical & Regulatory Writing

0 (0 reviews) Techno-Functional

Learn structured review methodologies to ensure accuracy, consistency, and regulatory compliance in medical and regulatory writing.

By Nomita Saxena

Last updated March 9, 2026

Current Status

Not Enrolled

Price

₹80,000.00

This intensive program on strategic review practices in medical and regulatory writing is designed for quality professionals in the pharmaceutical industry. The course focuses on structured review methodologies used to ensure the accuracy, clarity, regulatory compliance, and scientific integrity of medical and regulatory documents. Participants will learn how to conduct effective quality reviews across documents such as clinical study reports, regulatory submissions, clinical summaries, and safety reports. Through practical examples and document review frameworks, the program equips professionals with the skills needed to maintain high-quality standards in pharmaceutical documentation.

Course Content

Expand All

Redefining the Role of a Reviewer 4 Topics

Expand

Lesson Content

0% Complete 0/4 Steps

Tactical vs Strategic Review – moving up the value chain

Role of the reviewer in regulatory success and risk mitigation

Industry Key Terms: compliance lens, regulatory intelligence, submission readiness

Key outcomes: From grammar policing to strategic partner

Dimensions of Strategic Review 6 Topics

Expand

Lesson Content

0% Complete 0/6 Steps

Clinical logic check – Are endpoints, efficacy & safety data aligned?

Regulatory risk assessment – Spotting vulnerabilities in protocols, CSRs, ISS/ISE

Statistical integrity – Detecting inconsistencies in tables, figures, listings (TFLs)

Messaging precision – Ensuring core scientific story, key messages, and labeling alignment

Key Terms: submission compliance, dossier quality, CTD modules, GCP alignment

Situational exercise: Reviewing a protocol synopsis with hidden inconsistencies

Levels of Review – The Layered Approach 5 Topics

Expand

Lesson Content

0% Complete 0/5 Steps

Technical: formatting, references, templates

Language: readability, clarity, regulatory style guides (eCTD, AMA)

Compliance: ICH, GCP, E3 guidance, company SOPs

Strategic: big-picture positioning & regulatory acceptability

Case-based discussion: Review escalation at different levels – when to stop, when to deep-dive

Red Flags & Quality Signals in Documents 5 Topics

Expand

Lesson Content

0% Complete 0/5 Steps

Missing/ambiguous endpoints, inconsistent data across documents

Over-interpretation of results, regulatory non-acceptability risks

Real-world examples of FDA queries, EMA objections, Health Authority rejections triggered by poor reviews

Key Terms: regulatory inspection readiness, data traceability, quality culture

Case Study: When a review saved a submission – and when it failed

Tools, Frameworks 4 Topics

Expand

Lesson Content

0% Complete 0/4 Steps

Structured review frameworks (5C model: Clarity, Consistency, Compliance, Clinical logic, Communication)

Reviewer’s checklists for CSRs, Protocols, CTD summaries

Tools: Track changes, redlining, annotation conventions, QC matrices

Situational drill: Spot-the-error using a structured checklist

Collaborative Review & Feedback Mastery 4 Topics

Expand

Lesson Content

0% Complete 0/4 Steps

Reviewer–Author dynamics: Giving feedback that drives improvement, not conflict

Techniques for constructive critique, review consolidation, and team alignment

Key Terms: document governance, authoring alignment, cross-functional synergy

Group exercise to consolidate conflicting reviewer comments

Simulation – Reviewer in Action 3 Topics

Expand

Lesson Content

0% Complete 0/3 Steps

Hands-on annotation of a CSR safety section and Protocol synopsis

Participants redline, annotate, and classify findings (technical, compliance, strategic)

What a regulator would flag, what adds value, and what distracts

Meet Your Instructor

Nomita Saxena

5 Course

0 Student

An experienced regulatory writing consultant, she brings 20+ years in medicine and pharma R&D, with leadership roles at AstraZeneca, Novo Nordisk, and Accenture. She specializes in clinical and regulatory documentation and now partners with global clients to deliver high-impact content and capability-building programs.